[ET Net News Agency, 16 September 2025] WUXI XDC (02268) rose 1.9% to HK$70.9.
It hits an intra-day high of HK$70.9, hitting a historical high, and an intra-day low of HK$67.85. The total shares traded was 3.66 million, with a value of HK$254.32m. The active buy/sell ratio is 57:43, with net buying turnover of HK$33.39m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$23.29m, with volume weighted average price of HK$69.242. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$17.58m, with volume weighted average price of HK$69.632. The stock has risen a combined 10.4% over the past 3 consecutive trading days.
Basic Information| Nominal | 70.900 | % Chg | +1.94% |
| High | 70.900 | Low | 67.850 |
| Shares Tr | 3.66m | Turnover | 254.32m |
| 10-D SMA | 66.505 | %H.V | 64.946 |
| 20-D SMA | 62.010 | VWAP | 69.398 |
| 50-D SMA | 57.764 | RSI14 | 66.821 |
Status: Hitting a historical high, active buy/sell ratio is 57:43, with net buying turnover of HK$33.39m, rising a combined 10.4% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| WUXI XDC (02268) | 70.90 | +1.94 |
| SINO BIOPHARM (01177) | 8.46 | -2.98 |
| 3SBIO (01530) | 31.96 | -0.12 |
| EVEREST MED (01952) | 59.15 | +1.63 |
| ASCENTAGE-B (06855) | 76.80 | +0.85 |
| SKB BIO-B (06990) | 506.50 | -0.49 |
| ZAI LAB (09688) | 25.18 | +0.64 |
| AKESO (09926) | 130.40 | +1.16 |
| INNOCARE (09969) | 17.10 | -3.99 |
| REMEGEN (09995) | 111.10 | +0.63 |
(ed)
